{
    "clinical_study": {
        "@rank": "4757", 
        "brief_summary": {
            "textblock": "The purpose of this registry is to (A) better describe the incidence and prevalence of\n      Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors,\n      such as environmental and occupational, that may be associated with the disease; (C) better\n      outline key demographic factors (such as age, race or ethnicity, gender, and family history\n      of individuals who are diagnosed with the disease) associated with the disease; and (D)\n      better examine the connection between ALS and other motor neuron disorders that can be\n      confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS."
        }, 
        "brief_title": "The National Amyotrophic Lateral Sclerosis Registry", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Amyotrophic Lateral Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Amyotrophic Lateral Sclerosis", 
                "Sclerosis", 
                "Motor Neuron Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - U.S. citizens 18 years of age or older\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "ALS cases in the United States"
            }
        }, 
        "enrollment": {
            "#text": "5000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01772602", 
            "org_study_id": "CDC-NCEH/ATSDR-5768"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Amyotrophic Lateral Sclerosis", 
            "Lou Gehrig's Disease", 
            "Motor Neuron Disease"
        ], 
        "lastchanged_date": "October 30, 2013", 
        "link": {
            "description": "Click here to enroll in the National ALS Registry", 
            "url": "http://www.cdc.gov/als"
        }, 
        "location": {
            "contact": {
                "email": "PMehta1@cdc.gov", 
                "last_name": "Paul Mehta, MD", 
                "phone": "770-488-0556"
            }, 
            "contact_backup": {
                "email": "dhorton@cdc.gov", 
                "last_name": "Kevin Horton, DrPH, MSPH", 
                "phone": "770-488-1555"
            }, 
            "facility": {
                "address": {
                    "city": "Atlanta", 
                    "country": "United States", 
                    "state": "Georgia", 
                    "zip": "30333"
                }, 
                "name": "CDC"
            }, 
            "investigator": {
                "last_name": "Paul Mehta, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "The National Amyotrophic Lateral Sclerosis Registry", 
        "overall_contact": {
            "email": "PMehta1@cdc.gov", 
            "last_name": "Paul Mehta, MD", 
            "phone": "770-488-0556"
        }, 
        "overall_contact_backup": {
            "email": "dhorton@cdc.gov", 
            "last_name": "Kevin Horton, DrPH, MSPH", 
            "phone": "770-488-1555"
        }, 
        "overall_official": {
            "affiliation": "Centers for Disease Control and Prevention", 
            "last_name": "Paul Mehta, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To determine the incidence and prevalence of Amyotrophic Lateral Sclerosis in the US.", 
            "measure": "The National Amyotrophic Lateral Sclerosis (ALS) Registry", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01772602"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "To learn more about the potential risk factors for ALS", 
            "measure": "Risk factors of ALS", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "Centers for Disease Control and Prevention", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Department of Veterans Affairs", 
                    "agency_class": "U.S. Fed"
                }, 
                {
                    "agency": "Centers for Medicare and Medicaid Services", 
                    "agency_class": "U.S. Fed"
                }
            ], 
            "lead_sponsor": {
                "agency": "Centers for Disease Control and Prevention", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "October 2010", 
        "study_design": "N/A", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "5 Years", 
        "verification_date": "October 2013"
    }
}